Shape change of blood platelets brought about by myelin basic protein and other basic polypeptides.
Basic proteins and polypeptides (BPP) such as myelin basic protein (MBP), polyornithine (M.W. 40,000), polylysine and protamine, which are known to cause neuronal depolarization in the central nervous system, induced a shape change reaction in blood platelets of various species, including man. This reaction was not accompanied by platelet aggregation or marked alterations of 5-hydroxytryptamine release. Cyclic nucleotide levels were also unchanged. The shape change induced by polyornithine was inhibited by heparin but not by antagonists of 5HT, catecholamines or gamma-aminobutryic acid, substances which are known to have no effect on the MBP-induced neuronal depolarization. Other basic substances, e.g. low molecular weight polyornithine (M.W. 4,000), cytochrome c, spermine and spermidine, did not induce either platelet shape change or (as shown before) neuronal depolarization. It is concluded, that 1) the shape change reaction of platelets seems to be a sensitive and simple means of detecting those BPP which induce functional changes in mammalian cells and 2) the use of platelets as models for neurons can be extended to include the action of BPP on the plasma membranes.
D000818:Animals; D001792:Blood Platelets / Q000166:cytology* / Q000187:drug effects; D000242:Cyclic AMP / Q000097:blood; D006152:Cyclic GMP / Q000097:blood; D006168:Guinea Pigs; D006801:Humans; D066298:In Vitro Techniques; D004676:Myelin Basic Protein / Q000494:pharmacology*; D009474:Neurons / Q000187:drug effects; D010455:Peptides / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D012701:Serotonin / Q000097:blood; D013045:Species Specificity
D004676:Myelin Basic Protein; D010455:Peptides; D012701:Serotonin; D000242:Cyclic AMP; D006152:Cyclic GMP